Clover Health Expects FY23 Adjusted EBITDA Of ($70)M-$(120)M; Prior View $(125)M-$(175)M
Portfolio Pulse from Benzinga Newsdesk
Clover Health has updated its FY23 Adjusted EBITDA forecast to a loss of $70M-$120M, an improvement from the previous estimate of a loss of $125M-$175M.
August 08, 2023 | 8:58 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Clover Health's revised FY23 Adjusted EBITDA forecast indicates a smaller loss than previously expected, which could be seen as a positive sign by investors.
Clover Health's revised forecast indicates that the company expects to reduce its losses in FY23. This could be seen as a sign of improving financial health, which may positively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100